Autoimmune Conditions Hub

Understanding Autoimmune Nursing Assessment

Autoimmune diseases occur when the immune system mistakenly targets the body’s own tissues. Loss of self-tolerance and dysregulated immune responses lead to inflammation and tissue damage. Conditions can be organ-specific (e.g. autoimmune hepatitis, type 1 diabetes) or systemic (e.g. lupus, rheumatoid arthritis), with overlapping presentations across multiple body systems.

Many disorders are linked to autoantibodies and specific HLA and other genetic variants; triggers often include infections, drugs, or environmental factors. Diagnosis combines clinical presentation, serology (e.g. ANA, dsDNA, RF, ANCA, anti-CCP, disease-specific antibodies), inflammatory markers (ESR, CRP), imaging, and sometimes histology. Nursing assessment focuses on multisystem clues — joint swelling, rashes, fatigue, mucosal involvement, and signs of organ damage.

Management aims to suppress abnormal immunity and control inflammation using immunosuppressants, biologics (TNF inhibitors, JAK inhibitors), DMARDs, and glucocorticoids, with multidisciplinary input from rheumatology, neurology, gastroenterology, or other specialties as needed. Treat-to-target and steroid-sparing strategies are emphasised; nursing care includes infection screening before immunosuppression, vaccination per guidelines, monitoring for drug toxicity, and patient education on flare recognition and self-management.

Core immunology and pathophysiology points

Autoimmunity arises from breakdown of central or peripheral tolerance, with autoreactive T and B cells driving tissue-targeted or systemic inflammation. Type II reactions involve antibody-mediated damage (e.g. myasthenia gravis); type III involves immune complex deposition (e.g. lupus nephritis); type IV involves cell-mediated damage (e.g. type 1 diabetes, rheumatoid arthritis). Many conditions show female predominance and clustering in patients or families with other autoimmune disease.